United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$34Mraised across 4 rounds since 2006, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by sec.govSEC filing: $15M sold, first sale Oct 2011
No investor was named in the report.
Reported by sec.govSEC filing: $5.8M sold, first sale Jun 2011
Draper Associates
Mercury Fund
Alta Partners
DFJ Frontier
Gideon Hixon Fund
Funk Ventures
PhillipCapitalFrom a historical funding record
From the SEC filings it signed: 11 on the team.
On the board, as filediDan JanneyDavid BrailerErnie StrapazonFrank FosterJohn BacichMartin SutterSally Crawford
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Mercury FundDraper AssociatesAlta PartnersDFJ FrontierArcturus CapitalGideon Hixon FundFunk VenturesHealth Evolution PartnersPhillipCapitalMissing a round, or an investor who was in one? Tell us.
Prolacta Bioscience's investors include Mercury Fund, Draper Associates, Alta Partners, DFJ Frontier and Arcturus Capital, and 4 more on record.
Prolacta Bioscience has raised $34M across 4 rounds since 2006.
Prolacta Bioscience's most recent round was a Series D of $15M in Nov 2011.
Its most recent round, $15M in Nov 2011, is also its largest on record.
Prolacta Bioscience's first round on record, in Nov 2006, was backed by Mercury Fund.
Prolacta Bioscience's latest named round is a Series D, in Nov 2011.
Prolacta Bioscience is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
